69557-55-7

Basic information

• Product Name: 1H-Benzimidazole,4,5-dimethyl-(9CI)
• Synonyms: 1H-Benzimidazole,4,5-dimethyl-(9CI);4,5-dimethyl-1H-benzimidazole;MFCD18807626
• CAS NO: 69557-55-7
• Molecular Formula: C₉H₁₀N₂
• Molecular Weight: 146.19
• EINECS: 947-533-3
• Product Categories: BENZIMIDAZOLE
• Mol File: 69557-55-7.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 1H-Benzimidazole,4,5-dimethyl-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Benzimidazole,4,5-dimethyl-(9CI)(69557-55-7)
• EPA Substance Registry System: 1H-Benzimidazole,4,5-dimethyl-(9CI)(69557-55-7)

Safety Data

• Hazardous Substances Data: 69557-55-7(Hazardous Substances Data)

Usage

Type of compound

benzimidazole derivative

Structure

a fused benzene and imidazole ring

Methyl groups

attached to the 4 and 5 positions of the benzimidazole ring

Potential applications

pharmaceuticals, agrochemicals

Bioactivity

has bioactive properties

Ability to act as a ligand

can bind to metal complexes

Use as a building block

can be used for the synthesis of various organic compounds

Specific uses and properties

may vary depending on the context and application.

Upstream product

• 64-18-6 formic acid 
• 41927-01-9 3,4-dimethyl-o-phenylenediamine 
• 20353-93-9 [3-(dimethylamino)-2-azaprop-2-en-1-ylidene]-dimethylammonium chloride 
• 64823-23-0 3,4-Dimethyl-2-nitroanilin 

Relevant articles and documents

Heterocyclic compounds as inhibitors of factor VIIa

The present invention relates generally to compounds that inhibit serine proteases. In particular it is directed to novel heterocyclic compounds, or a stereoisomer or pharmaceutically acceptable salt, solvate, or prodrug form thereof, which are useful as selective inhibitors of serine protease enzymes of the coagulation cascade; for example thrombin, factor VIIa, factor Xa, factor XIa, factor IXa, and/or plasma kallikrein. In particular, it relates to compounds that are factor VIIa inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same.

ONE ATOM LYNCH PIN TRANSFORMATIONS OF GOLD'S REAGENT

A series of o-phenylenediamines and o-aminophenols have been reacted with Gold's reagent to yield benzimidazoles and benzoxazoles, respectively.Additionally, o-hydroxyacetophenone and anthranilamide, when reacted with Gold's reagent, were found to produce chromone and 3H-quinazoline-4-one, respectively.These transformations represent the use of Gold's reagent as a one atom lynch pin.